Circadian Feeding and Reciprocal Scent Intervention in NICU
Babies Nourished by the Rhythm of Time: Maternal and Fetal Effects of Circadian Feeding and Reciprocal Scent Intervention in Neonatal Intensive Care
Objective: This study evaluated the effects of circadian-aligned feeding and reciprocal scent intervention on premature infants receiving mechanical ventilation and on postpartum depression levels in their mothers.
Methods: In this randomized controlled trial, 75 premature infants and their mothers were assigned to reciprocal scent, circadian feeding, or control groups (n=25 each). Interventions were applied for 21 days. Outcomes included time to weaning from mechanical ventilation, weight gain, hydration status, breast milk production, and maternal Edinburgh Postnatal Depression Scale (EPDS) scores.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
This randomized controlled trial is designed to evaluate the effects of circadian-aligned feeding and reciprocal scent intervention, both alone and in combination, on clinical outcomes in premature infants receiving mechanical ventilation support and on postpartum depression levels in their mothers.
A total of 75 premature infants and their mothers will be enrolled and randomly assigned to one of three groups: a reciprocal scent intervention group, a circadian-aligned feeding group, or a control group (25 infant-mother dyads per group).
The interventions will be implemented for 21 days during the infants' hospitalization period. The primary outcome measure is time to weaning from mechanical ventilation. Secondary outcome measures include daily weight gain, hydration status assessed through diaper weight, daily breast milk production, and maternal postpartum depression assessed using the Edinburgh Postnatal Depression Scale (EPDS).
The study aims to determine whether these non-pharmacological interventions are associated with improvements in neonatal clinical outcomes and maternal psychological well-being.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Sanliurfa, Turquie (Türkiye)
- Sanliurfa Neonatal Intensive Care Unit
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
Accepte les volontaires sains
La description
Inclusion Criteria: Preterm neonates born before 37 weeks of gestation
- Intubated neonates requiring mechanical ventilation support
- Within the first 24 hours after birth
- Receiving enteral feeding
- Mothers willing to participate in the study
Exclusion Criteria:
- Congenital anomalies or major malformations
- Genetic syndromes or severe systemic diseases
- Contraindications to breastfeeding (e.g., maternal HIV infection or cytotoxic drug use)
- Inability of mothers to participate in study procedures
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Reciprocal Scent Group
Participants received circadian-aligned feeding combined with reciprocal maternal-infant scent intervention for 21 days.
|
Maternal-infant reciprocal scent exposure combined with circadian-aligned feeding.
|
|
Expérimental: Circadian Feeding Group
Participants received circadian-aligned breast milk feeding based on milk expression timing for 21 days.
|
Breast milk feeding synchronized with the timing of milk expression according to circadian rhythm.
|
|
Autre: Control Group
Participants received standard neonatal intensive care without additional sensory or circadian intervention.
|
Soins standard
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
ime to Weaning From Mechanical Ventilation
Délai: 21 days
|
Duration from initiation of mechanical ventilation to successful extubation without reintubation for at least 48 hours.
|
21 days
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Daily Weight Gain
Délai: Baseline to Day 21
|
Change in neonatal body weight measured daily during the intervention period.
|
Baseline to Day 21
|
|
Breast Milk Volume
Délai: Weekly during 21 days
|
Daily expressed breast milk volume produced by mothers during the intervention period.
|
Weekly during 21 days
|
|
Hydration Status (Diaper Weight)
Délai: Baseline to Day 21
|
Neonatal hydration status assessed by diaper weight measurements during routine diaper changes.
|
Baseline to Day 21
|
|
Edinburgh Postnatal Depression Scale (EPDS) Score
Délai: Baseline and Day 21
|
Maternal postpartum depression symptoms assessed using the Edinburgh Postnatal Depression Scale.
Edinburgh Postnatal Depression Scale (EPDS) is a validated screening tool for postpartum depressive symptoms.
The total score ranges from 0 to 30, with higher scores indicating more severe depressive symptoms and a worse outcome.
|
Baseline and Day 21
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Maladies urogénitales
- Maladies urogénitales féminines et complications de la grossesse
- Travail obstétrique, prématuré
- Complications du travail obstétrical
- Complications de grossesse
- Naissance prématurée
- Administration des services de santé
- Qualité des soins de santé, accès et évaluation
- Qualité des soins de santé
- Indicateurs de qualité, soins de santé
- Standard de soins
Autres numéros d'identification d'étude
- 2025/8378
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .